CA1119922A - Synthetic substitute stool material - Google Patents
Synthetic substitute stool materialInfo
- Publication number
- CA1119922A CA1119922A CA000304546A CA304546A CA1119922A CA 1119922 A CA1119922 A CA 1119922A CA 000304546 A CA000304546 A CA 000304546A CA 304546 A CA304546 A CA 304546A CA 1119922 A CA1119922 A CA 1119922A
- Authority
- CA
- Canada
- Prior art keywords
- matrix
- weight
- water
- lubricant
- brown
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000463 material Substances 0.000 title claims abstract description 66
- 239000011159 matrix material Substances 0.000 claims abstract description 47
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 35
- 239000000314 lubricant Substances 0.000 claims abstract description 23
- 239000004150 EU approved colour Substances 0.000 claims abstract description 8
- 229940006093 opthalmologic coloring agent diagnostic Drugs 0.000 claims abstract description 8
- 239000004615 ingredient Substances 0.000 claims abstract description 7
- 125000004430 oxygen atom Chemical group O* 0.000 claims abstract description 6
- 229920000620 organic polymer Polymers 0.000 claims abstract description 5
- 229910003480 inorganic solid Inorganic materials 0.000 claims abstract description 3
- 239000011343 solid material Substances 0.000 claims abstract description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 28
- PNEYBMLMFCGWSK-UHFFFAOYSA-N Alumina Chemical compound [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 26
- 238000004040 coloring Methods 0.000 claims description 22
- 239000003755 preservative agent Substances 0.000 claims description 19
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 claims description 18
- 229920002678 cellulose Polymers 0.000 claims description 17
- 239000001913 cellulose Substances 0.000 claims description 17
- 239000003795 chemical substances by application Substances 0.000 claims description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 15
- 239000000203 mixture Substances 0.000 claims description 15
- 235000011187 glycerol Nutrition 0.000 claims description 14
- 229920002307 Dextran Polymers 0.000 claims description 13
- 239000000049 pigment Substances 0.000 claims description 12
- 230000002335 preservative effect Effects 0.000 claims description 12
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 10
- 150000001720 carbohydrates Chemical class 0.000 claims description 8
- 235000014633 carbohydrates Nutrition 0.000 claims description 8
- 229920002401 polyacrylamide Polymers 0.000 claims description 8
- 239000004952 Polyamide Substances 0.000 claims description 6
- 239000003086 colorant Substances 0.000 claims description 6
- 229920002647 polyamide Polymers 0.000 claims description 6
- KUIXZSYWBHSYCN-UHFFFAOYSA-L remazol brilliant blue r Chemical compound [Na+].[Na+].C1=C(S([O-])(=O)=O)C(N)=C2C(=O)C3=CC=CC=C3C(=O)C2=C1NC1=CC=CC(S(=O)(=O)CCOS([O-])(=O)=O)=C1 KUIXZSYWBHSYCN-UHFFFAOYSA-L 0.000 claims description 6
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 claims description 6
- 229920003086 cellulose ether Polymers 0.000 claims description 5
- OVFWQJVENRZWTG-UHFFFAOYSA-L disodium 5-hydroxy-6-[[3-(2-sulfonatooxyethylsulfonyl)phenyl]diazenyl]naphthalene-1-sulfonate Chemical compound [Na+].[Na+].Oc1c(ccc2c(cccc12)S([O-])(=O)=O)N=Nc1cccc(c1)S(=O)(=O)CCOS([O-])(=O)=O OVFWQJVENRZWTG-UHFFFAOYSA-L 0.000 claims description 5
- 239000000975 dye Substances 0.000 claims description 5
- 229910052742 iron Inorganic materials 0.000 claims description 5
- 239000001034 iron oxide pigment Substances 0.000 claims description 5
- COEZWFYORILMOM-UHFFFAOYSA-N sodium 4-[(2,4-dihydroxyphenyl)diazenyl]benzenesulfonic acid Chemical compound [Na+].OC1=CC(O)=CC=C1N=NC1=CC=C(S(O)(=O)=O)C=C1 COEZWFYORILMOM-UHFFFAOYSA-N 0.000 claims description 5
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims description 4
- 108010010803 Gelatin Proteins 0.000 claims description 4
- 239000002202 Polyethylene glycol Substances 0.000 claims description 4
- 235000009470 Theobroma cacao Nutrition 0.000 claims description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 4
- 239000008273 gelatin Substances 0.000 claims description 4
- 229920000159 gelatin Polymers 0.000 claims description 4
- 235000019322 gelatine Nutrition 0.000 claims description 4
- 235000011852 gelatine desserts Nutrition 0.000 claims description 4
- 239000002245 particle Substances 0.000 claims description 4
- 229920001223 polyethylene glycol Polymers 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 239000007787 solid Substances 0.000 claims description 4
- 239000005711 Benzoic acid Substances 0.000 claims description 3
- 229920002302 Nylon 6,6 Polymers 0.000 claims description 3
- 235000010233 benzoic acid Nutrition 0.000 claims description 3
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 claims description 3
- 108090000623 proteins and genes Proteins 0.000 claims description 3
- 102000004169 proteins and genes Human genes 0.000 claims description 3
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims description 3
- 235000010234 sodium benzoate Nutrition 0.000 claims description 3
- 239000004299 sodium benzoate Substances 0.000 claims description 3
- 235000010199 sorbic acid Nutrition 0.000 claims description 3
- 239000004334 sorbic acid Substances 0.000 claims description 3
- 229940075582 sorbic acid Drugs 0.000 claims description 3
- 229930014626 natural product Natural products 0.000 claims description 2
- 150000005846 sugar alcohols Polymers 0.000 claims description 2
- 235000013980 iron oxide Nutrition 0.000 claims 3
- 239000008187 granular material Substances 0.000 claims 2
- VBMVTYDPPZVILR-UHFFFAOYSA-N iron(2+);oxygen(2-) Chemical class [O-2].[Fe+2] VBMVTYDPPZVILR-UHFFFAOYSA-N 0.000 claims 2
- 125000003277 amino group Chemical group 0.000 claims 1
- 239000001058 brown pigment Substances 0.000 claims 1
- 244000240602 cacao Species 0.000 claims 1
- QDOXWKRWXJOMAK-UHFFFAOYSA-N dichromium trioxide Chemical compound O=[Cr]O[Cr]=O QDOXWKRWXJOMAK-UHFFFAOYSA-N 0.000 claims 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims 1
- 125000005395 methacrylic acid group Chemical group 0.000 claims 1
- 229920000058 polyacrylate Polymers 0.000 claims 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims 1
- 229920002554 vinyl polymer Polymers 0.000 claims 1
- 238000002405 diagnostic procedure Methods 0.000 abstract description 6
- 210000004369 blood Anatomy 0.000 description 42
- 239000008280 blood Substances 0.000 description 42
- 238000012360 testing method Methods 0.000 description 33
- 235000010980 cellulose Nutrition 0.000 description 12
- 238000001514 detection method Methods 0.000 description 12
- 241000190019 Guaiacum Species 0.000 description 8
- 235000004440 Guaiacum sanctum Nutrition 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 7
- 239000008108 microcrystalline cellulose Substances 0.000 description 7
- 229940016286 microcrystalline cellulose Drugs 0.000 description 7
- 239000000470 constituent Substances 0.000 description 5
- 238000010998 test method Methods 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 229920001479 Hydroxyethyl methyl cellulose Polymers 0.000 description 3
- 229920005654 Sephadex Polymers 0.000 description 3
- 239000012507 Sephadex™ Substances 0.000 description 3
- 244000299461 Theobroma cacao Species 0.000 description 3
- 229940067573 brown iron oxide Drugs 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 102000003992 Peroxidases Human genes 0.000 description 2
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 description 2
- WXBLLCUINBKULX-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1.OC(=O)C1=CC=CC=C1 WXBLLCUINBKULX-UHFFFAOYSA-N 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000013068 control sample Substances 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 210000003608 fece Anatomy 0.000 description 2
- -1 for example Proteins 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 229910010272 inorganic material Inorganic materials 0.000 description 2
- 239000011147 inorganic material Substances 0.000 description 2
- YLGXILFCIXHCMC-JHGZEJCSSA-N methyl cellulose Chemical compound COC1C(OC)C(OC)C(COC)O[C@H]1O[C@H]1C(OC)C(OC)C(OC)OC1COC YLGXILFCIXHCMC-JHGZEJCSSA-N 0.000 description 2
- 108040007629 peroxidase activity proteins Proteins 0.000 description 2
- KJFMBFZCATUALV-UHFFFAOYSA-N phenolphthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2C(=O)O1 KJFMBFZCATUALV-UHFFFAOYSA-N 0.000 description 2
- 238000003908 quality control method Methods 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 238000004088 simulation Methods 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- NUIURNJTPRWVAP-UHFFFAOYSA-N 3,3'-Dimethylbenzidine Chemical compound C1=C(N)C(C)=CC(C=2C=C(C)C(N)=CC=2)=C1 NUIURNJTPRWVAP-UHFFFAOYSA-N 0.000 description 1
- YRNWIFYIFSBPAU-UHFFFAOYSA-N 4-[4-(dimethylamino)phenyl]-n,n-dimethylaniline Chemical compound C1=CC(N(C)C)=CC=C1C1=CC=C(N(C)C)C=C1 YRNWIFYIFSBPAU-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 102000008934 Muscle Proteins Human genes 0.000 description 1
- 108010074084 Muscle Proteins Proteins 0.000 description 1
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- 101100409194 Rattus norvegicus Ppargc1b gene Proteins 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- HFACYLZERDEVSX-UHFFFAOYSA-N benzidine Chemical compound C1=CC(N)=CC=C1C1=CC=C(N)C=C1 HFACYLZERDEVSX-UHFFFAOYSA-N 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 238000012505 colouration Methods 0.000 description 1
- MGNCLNQXLYJVJD-UHFFFAOYSA-N cyanuric chloride Chemical compound ClC1=NC(Cl)=NC(Cl)=N1 MGNCLNQXLYJVJD-UHFFFAOYSA-N 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 229940075894 denatured ethanol Drugs 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 238000005227 gel permeation chromatography Methods 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- JGGQWILNAAODRS-UHFFFAOYSA-N n-methyl-4-[4-(methylamino)phenyl]aniline Chemical compound C1=CC(NC)=CC=C1C1=CC=C(NC)C=C1 JGGQWILNAAODRS-UHFFFAOYSA-N 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- HJHVQCXHVMGZNC-JCJNLNMISA-M sodium;(2z)-2-[(3r,4s,5s,8s,9s,10s,11r,13r,14s,16s)-16-acetyloxy-3,11-dihydroxy-4,8,10,14-tetramethyl-2,3,4,5,6,7,9,11,12,13,15,16-dodecahydro-1h-cyclopenta[a]phenanthren-17-ylidene]-6-methylhept-5-enoate Chemical compound [Na+].O[C@@H]([C@@H]12)C[C@H]3\C(=C(/CCC=C(C)C)C([O-])=O)[C@@H](OC(C)=O)C[C@]3(C)[C@@]2(C)CC[C@@H]2[C@]1(C)CC[C@@H](O)[C@H]2C HJHVQCXHVMGZNC-JCJNLNMISA-M 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T436/105831—Protein or peptide standard or control [e.g., hemoglobin, etc.]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T436/106664—Blood serum or blood plasma standard or control
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DEP2724438.8 | 1977-05-31 | ||
| DE19772724438 DE2724438C2 (de) | 1977-05-31 | 1977-05-31 | Künstlicher Stuhl zu diagnostischen Zwecken |
| DEP2819284.9 | 1978-05-02 | ||
| DE2819284A DE2819284C2 (de) | 1977-05-31 | 1978-05-02 | Künstlicher Stuhl zu diagnostischen Zwecken |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1119922A true CA1119922A (en) | 1982-03-16 |
Family
ID=25772079
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000304546A Expired CA1119922A (en) | 1977-05-31 | 1978-05-31 | Synthetic substitute stool material |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US4394452A (OSRAM) |
| JP (1) | JPS5417794A (OSRAM) |
| AT (1) | AT360660B (OSRAM) |
| CA (1) | CA1119922A (OSRAM) |
| CH (1) | CH636965A5 (OSRAM) |
| DE (1) | DE2819284C2 (OSRAM) |
| FR (1) | FR2393309A1 (OSRAM) |
| GB (1) | GB1579102A (OSRAM) |
| IT (1) | IT1203184B (OSRAM) |
| SE (1) | SE443239B (OSRAM) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3827561C1 (OSRAM) * | 1988-08-13 | 1989-12-28 | Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De | |
| US5385844A (en) * | 1993-04-22 | 1995-01-31 | Boehringer Mannheim Corporation | Polymer containing control reagents and polymers useful in control reagents |
| AU6918294A (en) * | 1993-06-10 | 1995-01-03 | Procter & Gamble Company, The | Synthetic fecal material |
| US5890907A (en) * | 1997-01-13 | 1999-04-06 | Clifford W. Estes Company, Inc. | Educational doll |
| CN1639575A (zh) * | 2001-10-05 | 2005-07-13 | 斯特里斯公司 | 用于抗朊病毒活性的体外模型 |
| US6933152B1 (en) * | 2003-04-04 | 2005-08-23 | Nerl Diagnostics | Artificial human feces |
| JP4544201B2 (ja) * | 2006-05-26 | 2010-09-15 | パナソニック電工株式会社 | 模擬便 |
| JP4544200B2 (ja) * | 2006-05-26 | 2010-09-15 | パナソニック電工株式会社 | 模擬便 |
| US20130052624A1 (en) * | 2011-08-25 | 2013-02-28 | Miguel Saps | Tridimensional stool assessment instrument, methods, and uses thereof |
| JP5957641B2 (ja) * | 2012-08-25 | 2016-07-27 | 彰 三池 | 擬似便組成物 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1600599A (en) * | 1926-03-29 | 1926-09-21 | Parker Maria Louisa | Model of the large intestine |
| GB432571A (en) * | 1934-01-30 | 1935-07-30 | Crosse & Blackwell Ltd | Improvements in and relating to sealing compositions for cans, jars and other containers |
| US2320098A (en) * | 1939-10-18 | 1943-05-25 | Quisling Sverre | Cosmetic coloring composition |
| US2699401A (en) * | 1949-11-17 | 1955-01-11 | Reardon Company | Texture paint |
| GB708996A (en) * | 1954-04-15 | 1954-05-12 | Miles Lab | Improvements in or relating to diagnostic compositions |
| US2925365A (en) * | 1957-11-27 | 1960-02-16 | Smith Kline French Lab | Coloring solid pharmaceutical forms and compositions therefor |
| US3427176A (en) * | 1962-11-28 | 1969-02-11 | Shikoku Chem | Three-dimensional coloring composition |
| US3933594A (en) * | 1974-08-16 | 1976-01-20 | Polaroid Corporation | Method and device for determining the concentration of a substance in a fluid |
-
1978
- 1978-05-02 DE DE2819284A patent/DE2819284C2/de not_active Expired
- 1978-05-16 AT AT351578A patent/AT360660B/de not_active IP Right Cessation
- 1978-05-24 GB GB21978/78A patent/GB1579102A/en not_active Expired
- 1978-05-30 IT IT68238/78A patent/IT1203184B/it active
- 1978-05-30 US US05/910,285 patent/US4394452A/en not_active Expired - Lifetime
- 1978-05-30 FR FR7816092A patent/FR2393309A1/fr active Granted
- 1978-05-30 SE SE7806291A patent/SE443239B/sv not_active IP Right Cessation
- 1978-05-31 JP JP6559378A patent/JPS5417794A/ja active Granted
- 1978-05-31 CA CA000304546A patent/CA1119922A/en not_active Expired
- 1978-05-31 CH CH596078A patent/CH636965A5/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CH636965A5 (de) | 1983-06-30 |
| FR2393309B1 (OSRAM) | 1982-12-31 |
| JPS5417794A (en) | 1979-02-09 |
| FR2393309A1 (fr) | 1978-12-29 |
| SE7806291L (sv) | 1978-12-01 |
| DE2819284A1 (de) | 1979-11-15 |
| ATA351578A (de) | 1980-06-15 |
| IT7868238A0 (it) | 1978-05-30 |
| SE443239B (sv) | 1986-02-17 |
| GB1579102A (en) | 1980-11-12 |
| JPS6236180B2 (OSRAM) | 1987-08-05 |
| US4394452A (en) | 1983-07-19 |
| AT360660B (de) | 1981-01-26 |
| IT1203184B (it) | 1989-02-15 |
| DE2819284C2 (de) | 1985-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1119922A (en) | Synthetic substitute stool material | |
| EP0226767B1 (de) | Transparentes Teststreifensystem | |
| Doran et al. | Bleeding patterns in colorectal cancer: the effect of aspirin and the implications for faecal occult blood testing | |
| EP0016387B1 (de) | Diagnostisches Mittel zum Nachweis von Bestandteilen von Flüssigkeiten | |
| US4615972A (en) | Stabilization of indicators for detecting enzyme activity | |
| Badin et al. | Plasma polysaccharide fraction containing uronic acid, in normal subjects and in patients with rheumatoid arthritis | |
| DE3202894A1 (de) | Verfahren zur bestimmung von tumor-assoziierten glykoprotein enthaltenden verbindungen, anwendung des verfahrens zur krebsdiagnose und kit fuer die anwendung des verfahrens | |
| EP0227602B1 (en) | Free flowing granular indicator material for peroxidase-like activity | |
| EP0545350A1 (de) | Multivalentes Dextranreagenz zum Einsatz in Präzipitationstests | |
| US5338513A (en) | Test carrier for the analytical determination of a component of a liquid sample | |
| DE68918504T2 (de) | Analyseelement vom Trockentyp für einen Immuntest. | |
| DE69211805T2 (de) | Testsatz und Verfahren zum Nachweiss von Mikroorganismen assoziiert mit periodontalen Krankheiten unter Verwendung Surfactantmischung als Extraktionskomposition | |
| EP0877938B1 (de) | Verfahren zur markierung von biomolekülen mit meerrettichperoxidase | |
| DE2934756A1 (de) | Zusammensetzung zur bestimmung von beta 2 -humanmikroglobulin und verfahren zu deren herstellung und deren verwendung | |
| US6933152B1 (en) | Artificial human feces | |
| Cherry et al. | Evaluation of commercial fluorescein isothiocyanates used in fluorescent antibody studies | |
| US5116762A (en) | Method for determining the concentration of fructosamine using a standard solution and method of calibrating the standard solution | |
| DE69021631T2 (de) | Diagnostische Zusammenstellung zum Nachweis von rheumatischer Arthritis. | |
| Seale et al. | Isolation and characterization of a polyamine-peptide conjugate from human amniotic fluid | |
| DE3852166T2 (de) | Analytische Vorrichtung für enzymimmunologische Tests. | |
| CA1313112C (en) | Analytical method and element for ferrous ion assay | |
| DE3850981T2 (de) | Wasserunlösliches Teilchen und immunoreaktives Reagens, analytische Elemente und Verfahren zu ihrer Verwendung. | |
| EP0107029A1 (en) | Control device and method for making same | |
| King et al. | Total nondialyzable solids (TNDS) in human urine. III. A method for subfractionation of RS-1 solids | |
| Nguyen et al. | In Vitro Binding of Vitamin B‐6 by Selected Polysaccharides, Lignin, and Wheat Bran |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry |